These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5598475)

  • 1. [Use of cetamiphen and nicotinic acid in the treatment of patients with coronary atherosclerosis].
    Savenkov PM
    Kardiologiia; 1967 Apr; 7(4):50-3. PubMed ID: 5598475
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of retabolyl on the lipid and protein metabolism of coronary atherosclerosis patients].
    Savenkov PM; Segal' RG
    Kardiologiia; 1969 Jul; 9(7):95-100. PubMed ID: 5372695
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of cetamiphen in patients with coronary arteriosclerosis].
    Savenkov PM
    Sov Med; 1966 Apr; 29(4):98-100. PubMed ID: 5984051
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of atromide-S (chlorfibrate) for the treatment of patients with coronary arteriosclerosis].
    Zadionchenko VS; Arshakuni RO; Zharov EI; Martynov AI; Liusov VA; Belousov IuB
    Kardiologiia; 1969 Apr; 9(4):73-7. PubMed ID: 5803361
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prolonged use of atromid in patients with coronary arteriosclerosis].
    Zadionchenko VS
    Kardiologiia; 1967 Oct; 7(10):32-5. PubMed ID: 5607197
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of cetamiphen on coagulative properties of blood in patients with coronary arteriosclerosis].
    Zelenskaia LM
    Vrach Delo; 1975 Jul; (7):68-70. PubMed ID: 1220236
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative evaluation of treatment of patients with coronary atherosclerosis with nicatol and nicotinic acid].
    Ivanchenko FT
    Vrach Delo; 1967 Jan; 1():76-80. PubMed ID: 4895148
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of trimanyl on lipid metabolism, hemodynamics and coronary blood flow in patients with arteriosclerosis of the coronary vessels].
    Savenkov PM; Zharov EI; Arshakuni RO
    Kardiologiia; 1967 Aug; 7(8):40-4. PubMed ID: 5615900
    [No Abstract]   [Full Text] [Related]  

  • 9. The coronary drug project. Design, methods, and baseline results.
    Circulation; 1973 Mar; 47(3 Suppl):I1-50. PubMed ID: 4570454
    [No Abstract]   [Full Text] [Related]  

  • 10. [Arteriosclerosis--nicotinic acid therapy. 7. Effect of nicotinic acid on lipoproteins].
    Carlson LA
    Lakartidningen; 1971 Apr; 68(15):1763-4. PubMed ID: 5577249
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
    Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term changes of serum cholesterol with cholesterol-altering drugs in patients with coronary heart disease. Veterans Administration Drug-Lipid Cooperative Study.
    Detre KM; Shaw L
    Circulation; 1974 Nov; 50(5):998-1005. PubMed ID: 4609636
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate.
    Nordoy A; Rodset JM
    Acta Med Scand; 1971 May; 189(5):385-9. PubMed ID: 5578488
    [No Abstract]   [Full Text] [Related]  

  • 14. CORONARY ARTERY DISEASE WITH SPECIAL REFERENCE TO THE EFFECTS OF CHOLESTEROL-LOWERING AGENTS.
    HERRMANN GR
    Med Bull (Ann Arbor); 1964; 30():12-8. PubMed ID: 14170885
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.
    Kannel WB; Castelli WP; Gordon T; McNamara PM
    Ann Intern Med; 1971 Jan; 74(1):1-12. PubMed ID: 5539274
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: After a coronary.
    Br Med J; 1975 Apr; 2(5963):103-5. PubMed ID: 1125693
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of Sadamin on lipid metabolism in patients with obliterative arteriosclerosis of lower limbs].
    Kiersnowska B; Bielawiec M; Lukjan H; Grabowski R; Korfel B
    Pol Tyg Lek; 1972 Jan; 27(4):133-5. PubMed ID: 5010169
    [No Abstract]   [Full Text] [Related]  

  • 18. [Significance of several biochemical methods for the diagnosis of outbreaks of humoral lipid distrubances in coronary ateriosclerosis].
    Fomina LG
    Kardiologiia; 1967 Nov; 7(11):124-30. PubMed ID: 5618296
    [No Abstract]   [Full Text] [Related]  

  • 19. [Favorable effect of nicotinic acid on lipoprotein normalization with temporary drug association].
    Ferliga G
    G Gerontol; 1967 Nov; 15(11):1381-7. PubMed ID: 5617990
    [No Abstract]   [Full Text] [Related]  

  • 20. [The combination preparation VisanoCor in patients with angina pectoris with special monitoring of urinary catecholamines].
    Hagel H
    Fortschr Med; 1981 Nov; 99(41):1714-7. PubMed ID: 7319440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.